Methylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 70010-015

8 FDA label images from Granules Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 70010-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Granules Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methylphenidate-fig-1-jpg.jpg (Methylphenidate Fig 1 Jpg)

Methylphenidate-fig-1-jpg.jpg (Methylphenidate Fig 1 Jpg)
A line graph showing mean d-methylphenidate plasma levels (ng/mL) over time (hours) comparing Methylphenidate Hydrochloride extended-release capsules 40 mg once daily versus methylphenidate hydrochloride tablets 20 mg twice daily in clinical study subjects. The graph displays plasma concentration curves for both formulations across a 24-hour period.*
FDA Label Image

Methylphenidate-figur-2-jpg.jpg (Methylphenidate Figur 2 Jpg)

Methylphenidate-figur-2-jpg.jpg (Methylphenidate Figur 2 Jpg)
A bar chart comparing mean score changes from baseline between methylphenidate hydrochloride extended-release capsules and placebo groups. The methylphenidate group (n=63) shows a negative mean final score change with an error bar, while the placebo group (n=71) shows a positive mean final score change with its own error bar. The x-axis labels represent the treatment groups, and the y-axis shows the mean score difference values.*
FDA Label Image

Methylphenidate-label1-jpg.jpg (Methylphenidate Label1 Jpg)

Methylphenidate-label1-jpg.jpg (Methylphenidate Label1 Jpg)
Methylphenidate Hydrochloride Extended-Release Capsules (LA) 60 mg, oral dosage form, in a 30-capsule package. Label shows once daily use and includes directions to dispense capsules separately for each patient. Manufactured by Granules Pharmaceuticals Inc. Contains 60 mg methylphenidate hydrochloride, USP per capsule.*
FDA Label Image

Methylphenidate-label2-jpg.jpg (Methylphenidate Label2 Jpg)

Methylphenidate-label2-jpg.jpg (Methylphenidate Label2 Jpg)
Label for Methylphenidate Hydrochloride extended-release capsules (LA) 10 mg by Granules Pharmaceuticals Inc. The label displays dosage strength as 10 mg, prescription-only status, and packaging in a 100 capsule bottle. It includes storage instructions, ingredients, and a note to dispense the Medication Guide separately to patients.*
FDA Label Image

Methylphenidate-label3-jpg.jpg (Methylphenidate Label3 Jpg)

Methylphenidate-label3-jpg.jpg (Methylphenidate Label3 Jpg)
Methylphenidate Hydrochloride Extended-Release Capsules 20 mg, oral dosage form, packaged as 100 capsules. The label includes NDC 70010-013-01 and indicates the product is manufactured by Granules Pharmaceuticals Inc. Instructions for storage, usage, and prescription details are visible on the label.*
FDA Label Image

Methylphenidate-label4-jpg.jpg (Methylphenidate Label4 Jpg)

Methylphenidate-label4-jpg.jpg (Methylphenidate Label4 Jpg)
Methylphenidate Hydrochloride Extended-Release Capsules 30 mg carton label showing that each capsule contains 30 mg of methylphenidate hydrochloride as the active ingredient. The label indicates the product is for oral use, prescribed once daily, and dispensed by the medication guide. The package contains 100 capsules supplied by Granules Pharmaceuticals Inc., Chantilly, VA.*
FDA Label Image

Methylphenidate-label5-jpg.jpg (Methylphenidate Label5 Jpg)

Methylphenidate-label5-jpg.jpg (Methylphenidate Label5 Jpg)
Label for Methylphenidate Hydrochloride Extended-Release Capsules by Granules Pharmaceuticals Inc., showing 40 mg strength. The label specifies 100 capsules per bottle, oral route, with instructions about dosage form and storage. It includes regulatory and manufacturing details.*
FDA Label Image

Methylphenidate-structure-jpg.jpg (Methylphenidate Structure Jpg)

Methylphenidate-structure-jpg.jpg (Methylphenidate Structure Jpg)
Chemical structure of Methylphenidate Hydrochloride showing the molecular arrangement including a phenyl ring, ester group, piperidine ring, and hydrochloride (HCl) salt component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.